Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morpheus-Head and Neck: Atezo + Tira Combinations
NCT05459129Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 3
01
Overview
A Phase 2 trial of tiragolumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Roche. Started Apr 2023; status: completed.
02
Drugs
tiragolumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT05459129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05459129.